Winner out of 30 startups at BioAlps BIND 2026
Dexterous Endoscopes won the BioAlps BIND 2026 Best Startup Award, selected out of 30 startups pitching in front of more than 340 participants from the life sciences ecosystem.
The award, sponsored by Lenz & Staehelin (CHF 5,000), recognizes high-potential startups developing impactful healthcare solutions. This recognition highlights the strong interest in Dexterous Endoscopes’ platform solution and its potential to enable new minimally invasive procedures in difficult-to-reach areas.
Several additional prizes were also awarded by sponsors, including one received by Molesense, another EPFL startup.
Source:
https://bioalps.org/bind-2026-crowns-four-life-sciences-winners/
More news
Selected for Venture Kick Stage 1
Dexterous Endoscopes won Venture Kick Stage 1 and CHF 10,000 in funding. The support will help validate our business case and advance variable stiffness endoscopes toward clinical adoption.
Dexterous Endoscopes awarded Bridge PoC Extension and Innovation Booster Robotics support with pilot study at CHUV
Dexterous Endoscopes secured an additional CHF 65k Bridge PoC grant and Innovation Booster Robotics support with CHUV Hospital as implementation partner. The funding enables multiple preclinical trials and a pilot study at CHUV to de-risk usability and performance.
Dexterous Endoscopes team and clinical advisors at ERS 2025 in Budapest
Dexterous Endoscopes and its clinical advisors presented the variable stiffness endoscope at ERS 2025 in Budapest, gathering feedback from ENT surgeons and securing new pilot studies with hospitals.